Trusted Resources: Education
Scientific literature and patient education texts
Fetal Therapies and Trials for Lysosomal Storage Diseases: A Survey of Attitudes of Parents and Patients
source: Orphanet journal of rare diseases
year: 2022
authors: Schwab ME,Brown JEH,Lianoglou B,Jin C,Conroy PC,Gallagher RC,Harmatz P,MacKenzie TC
summary/abstract:Lysosomal storage diseases (LSDs) are inherited metabolic disorders that may lead to severe multi-organ disease. Current ERTs are limited by anti-drug antibodies, the blood-brain barrier, and early disease onset and progression before ERT is started. We have opened a phase I clinical trial of enzyme replacement therapy (ERT) for fetuses with LSDs (NCT04532047). We evaluated the attitudes of parents and patients with LSDs towards fetal clinical trials and therapies.
organization: Fetal Treatment Center, University of California, San Francisco, CA, USA.DOI: 10.1186/s13023-022-02178-z
read more
BookmarkRelated Content
-
Mucopolysaccharidosis Type I Disease Prevalence Among Patients With Idiopathic Short Stature in Saudi Arabia: Protoc...Since the underlying cause of idiopathic...
-
Enzyme Replacement Therapy With Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis o...Enzyme replacement therapy (ERT) improve...
-
Real-World Data Assessment of Safety of Home-Based and Hospital/Outpatient-Based laronidase Enzyme Replacement Thera...Enzyme replacement therapy (ERT) is avai...
-
Clinical and Event-Based Outcomes of Patients With Mucopolysaccharidosis VI Receiving Enzyme Replacement Therapy in ...The objective of this study was to descr...
-
The MPS I-H Diagnostic Journeyhttps://www.youtube.com/watch?v=jSq5tQD4...
-
Enzyme Replacement Therapy With Galsulfase for Mucopolysaccharidosis Type VIMucopolysaccharidosis type VI (MPS VI) o...
-
Case Report: Cerebral Revascularization in a Child With Mucopolysaccharidosis Type IMucopolysaccharidosis (MPS) type I is a ...
Powered by
